Robert van Waterschoot, based in Basel, BS, CH, is currently a Group Head DMPK and PD Leaders at Roche, bringing experience from previous roles at Roche, AbbVie (formerly Abbott) and Abbott. Robert van Waterschoot holds a 2005 - 2009 PhD in Drug Toxicity and Pharmacokinetics @ Utrecht University. With a robust skill set that includes Pharmacokinetics, Drug Metabolism, ADME, Drug Discovery, DMPK and more, Robert van Waterschoot contributes valuable insights to the industry. Robert van Waterschoot has 1 email on RocketReach.